{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:26:11Z","timestamp":1775798771199,"version":"3.50.1"},"reference-count":142,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UI\/BD\/151314\/2021"],"award-info":[{"award-number":["UI\/BD\/151314\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/98304\/2013"],"award-info":[{"award-number":["SFRH\/BPD\/98304\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Although cannabinoids have been used for centuries for diverse pathological conditions, recently, their clinical interest and application have emerged due to their diverse pharmacological properties. Indeed, it is well established that cannabinoids exert important actions on multiple sclerosis, epilepsy and pain relief. Regarding cancer, cannabinoids were first introduced to manage chemotherapy-related side effects, though several studies demonstrated that they could modulate the proliferation and death of different cancer cells, as well as angiogenesis, making them attractive agents for cancer treatment. In relation to breast cancer, it has been suggested that estrogen receptor-negative (ER\u2212) cells are more sensitive to cannabinoids than estrogen receptor-positive (ER+) cells. In fact, most of the studies regarding their effects on breast tumors have been conducted on triple-negative breast cancer (TNBC). Nonetheless, the number of studies on human epidermal growth factor receptor 2-positive (HER2+) and ER+ breast tumors has been rising in recent years. However, besides the optimistic results obtained thus far, there is still a long way to go to fully understand the role of these molecules. This review intends to help clarify the clinical potential of cannabinoids for each breast cancer subtype.<\/jats:p>","DOI":"10.3390\/molecules27010156","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T06:55:03Z","timestamp":1640674503000},"page":"156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype"],"prefix":"10.3390","volume":"27","author":[{"given":"Cristina Ferreira","family":"Almeida","sequence":"first","affiliation":[{"name":"Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"},{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"}]},{"given":"Nat\u00e9rcia","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"},{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5787-9018","authenticated-orcid":false,"given":"Georgina","family":"Correia-da-Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"},{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"}]},{"given":"Cristina","family":"Amaral","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"},{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n\u00b0 228, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5740\/jaoacint.18-0208","article-title":"A brief background on cannabis: From plant to medical indications","volume":"102","author":"Klumpers","year":"2019","journal-title":"J. AOAC Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: The first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_3","unstructured":"De Meijer, E.P.M., and Pertweem, R.G. (2014). Handbook of Cannabis. Handbooks in Psychopharmacology, Oxford University Press."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/dta.1529","article-title":"Therapeutic potential of cannabinoid medicines","volume":"6","author":"Robson","year":"2014","journal-title":"Drug Test. Anal."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prostaglandins.2013.02.002","article-title":"Endogenous cannabinoids revisited: A biochemistry perspective","volume":"102-103","author":"Fonseca","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2174\/092986711795471374","article-title":"The endocannabinoid system in the cancer therapy: An overview","volume":"18","author":"Grimaldi","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000492757","article-title":"A survey on the medical use of cannabis in Europe: A position paper","volume":"24","author":"Bramness","year":"2018","journal-title":"Eur. Addict. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/092986711794940888","article-title":"Cannabinoids: Occurrence and medicinal chemistry","volume":"18","author":"Chianese","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_9","first-page":"S2","article-title":"The cannabis crop","volume":"525","author":"Gould","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104822","DOI":"10.1016\/j.phrs.2020.104822","article-title":"Cannabis sativa: Much more beyond \u03949-tetrahydrocannabinol","volume":"157","author":"Alves","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2019.11.002","article-title":"Missing pieces to the endocannabinoid puzzle","volume":"26","author":"Maccarrone","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13543784.2019.1561859","article-title":"Cannabis for cancer\u2014Illusion or the tip of an iceberg: A review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology","volume":"28","author":"Turgeman","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/13543784.2016.1236913","article-title":"Phyto-, endo- and synthetic cannabinoids: Promising chemotherapeutic agents in the treatment of breast and prostate carcinomas","volume":"25","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kinghorn, A., Falk, H., Gibbons, S., and Kobayashi, J. (2017). Phytochemistry of Cannabis sativa L.. Phytocannabinoids. Progress in the Chemistry of Organic Natural Products, Springer.","DOI":"10.1007\/978-3-319-45541-9"},{"key":"ref_16","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Fonseca","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"ref_17","first-page":"532","article-title":"Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes","volume":"26","author":"Howlett","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"ref_18","first-page":"429","article-title":"Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes","volume":"27","author":"Howlett","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/0024-3205(84)90278-9","article-title":"Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds","volume":"35","author":"Howlett","year":"1984","journal-title":"Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0378-1119(03)00638-3","article-title":"Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates","volume":"312","author":"McPartland","year":"2003","journal-title":"Gene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures\u2014A short review","volume":"90","author":"Sulcova","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1093\/nar\/19.17.4798-a","article-title":"HindIII identifies a two allele DNA polymorphism of the human cannabinoid receptor gene (CNR)","volume":"19","author":"Caenazzo","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"ref_24","first-page":"880","article-title":"Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15","volume":"3","author":"Hoehe","year":"1991","journal-title":"New Biol."},{"key":"ref_25","first-page":"561","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nat. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zou, S., and Kumar, U. (2018). Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030833"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jacc.2005.12.067","article-title":"Rimonabant: A cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors","volume":"47","author":"Gelfand","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Pisanti","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease-successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"ref_31","first-page":"602","article-title":"High-resolution crystal structure of the human CB1 cannabinoid receptor","volume":"540","author":"Shao","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, & Psi;GPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol. Brain Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and Its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnbeh.2012.00009","article-title":"The endocannabinoid system: An overview","volume":"6","author":"Battista","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB1and CB2Receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_41","first-page":"443","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"ref_42","first-page":"452","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors","volume":"152","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0006-2952(93)90486-G","article-title":"Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist","volume":"46","author":"Deutsch","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0021-9258(18)33114-4","article-title":"Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate","volume":"258","author":"Prescott","year":"1983","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-3084(00)00189-4","article-title":"2-Arachidonoylglycerol and the cannabinoid receptors","volume":"108","author":"Sugiura","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(98)00075-1","article-title":"Cannabis and endogenous cannabinoid systems","volume":"51","author":"Childers","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2005.05.032","article-title":"Anandamide induced PPAR\u03b3 transcriptional activation and 3T3-L1 preadipocyte differentiation","volume":"517","author":"Bouaboula","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2011.01444.x","article-title":"Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-\u03b3","volume":"163","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_51","first-page":"158807","article-title":"Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta","volume":"1865","author":"Maia","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm960752x","article-title":"Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor","volume":"40","author":"Sheskin","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjp.0705607","article-title":"Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors","volume":"141","author":"Leggett","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/npp.2017.130","article-title":"Circulating endocannabinoids: From whence do they Come and where are they going?","volume":"43","author":"Hillard","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.plipres.2019.101019","article-title":"The (endo)cannabinoid signaling in female reproduction: What are the latest advances?","volume":"77","author":"Cecconi","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Velasco","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.7150\/ijms.27087","article-title":"Cannabinoids: From pot to lab","volume":"15","author":"Papaseit","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_63","first-page":"9","article-title":"Cannabinoid-induced tetrad in mice","volume":"80","author":"Grel","year":"2017","journal-title":"Curr. Protoc. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2990.2011.01248.x","article-title":"\u03949-tetrahydrocannabinol (\u03949-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson\u2019s disease","volume":"38","author":"Carroll","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2016.09.008","article-title":"\u03949-Tetrahydrocannabinol reverses TNF\u03b1-induced increase in airway epithelial cell permeability through CB2 receptors","volume":"120","author":"Shang","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_67","first-page":"2114","article-title":"Prevalence of marijuana use disorders in the United States: 1991\u20131992 and 2001\u20132002","volume":"291","author":"Compton","year":"2004","journal-title":"JAMA Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/ja01865a080","article-title":"Isolation of cannabinol, cannabidiol and quebrachitol from red oil of minnesota wild hemp","volume":"62","author":"Adams","year":"1940","journal-title":"J. Am. Chem. Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish\u2014I: The structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"ref_70","first-page":"1","article-title":"Toxicological properties of \u03949-tetrahydrocannabinol and cannabidiol","volume":"71","year":"2020","journal-title":"Arch. Ind. Hyg. Toxicol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"LaPrairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Varani","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: State of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Atalay, S., Jarocka-Karpowicz, I., and Skrzydlewska, E. (2019). Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants, 9.","DOI":"10.3390\/antiox9010021"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_76","unstructured":"Gaoni, Y., and Mechoulam, R. (1964). The structure and synthesis of cannabigerol, a new hashish constituent. Proceedings of the Chemical Society, RSC Publishing."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","article-title":"Isolation and structure of. DELTA.+-tetrahydrocannabinol and other neutral cannabinoids from hashish","volume":"93","author":"Gaoni","year":"1971","journal-title":"J. Am. Chem. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0040-4039(01)87494-3","article-title":"Hashish. XX. Cannabidivarin, a new hashish constituent","volume":"3","author":"Vollner","year":"1969","journal-title":"Tetrahedron Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","article-title":"Cannabidivarin is anticonvulsant in mouse and rat","volume":"167","author":"Hill","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","article-title":"Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures","volume":"46","author":"Rosenthaler","year":"2014","journal-title":"Neurotoxicology Teratol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bph.12321","article-title":"Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1receptor-independent mechanism","volume":"170","author":"Hill","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"Ligresti","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","article-title":"GPR3, GPR6, and GPR12 as novel molecular targets: Their biological functions and interaction with cannabidiol","volume":"40","author":"Laun","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of l-\u03b1-lysophosphatidylinositol\/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Baillie","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(03)00381-8","article-title":"The therapeutic potential of cannabis","volume":"2","author":"Baker","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-017-0720-6","article-title":"Delta-9-tetrahydrocannabinol\/cannabidiol oromucosal spray (Sativex\u00ae): A review in multiple sclerosis-related spasticity","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-0114-4","article-title":"An update of current cannabis-based pharmaceuticals in pain medicine","volume":"8","author":"Urits","year":"2019","journal-title":"Pain Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/1060028018822124","article-title":"Cannabidiol: A new hope for patients with dravet or Lennox-Gastaut syndromes","volume":"53","author":"Chen","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/14728222.2011.553606","article-title":"Update on the endocannabinoid system as an anticancer target","volume":"15","author":"Malfitano","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/112_2017_3","article-title":"Cannabinoids as modulators of cell death: Clinical applications and future directions","volume":"173","author":"Fonseca","year":"2017","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ctrv.2012.06.005","article-title":"Cannabinoids: A new hope for breast cancer therapy?","volume":"38","author":"Caffarel","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic activity of cannabinoids2","volume":"55","author":"Munson","year":"1975","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbacli.2017.01.001","article-title":"Understanding breast cancer\u2014The long and winding road","volume":"7","author":"Lukong","year":"2017","journal-title":"BBA Clin."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsbmb.2015.05.005","article-title":"From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?","volume":"153","author":"Wu","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014Dealing with the diversity of breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"personalizing the treatment of women with early breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.soc.2017.08.005","article-title":"Molecular subtypes and local-regional control of breast cancer","volume":"27","author":"Fragomeni","year":"2018","journal-title":"Surg. Oncol. Clin. North Am."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.breast.2018.03.006","article-title":"HER2-positive breast cancer: Current and new therapeutic strategies","volume":"39","author":"Bellet","year":"2018","journal-title":"Breast"},{"key":"ref_101","unstructured":"Society, A.C. (2019). Breast Cancer Facts & Figure 2019 and Figure 2020, American Cancer Society, Inc."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jbi\/wbaa110","article-title":"Molecular subtypes of breast cancer: A review for breast radiologists","volume":"3","author":"Johnson","year":"2021","journal-title":"J. Breast Imaging"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cam4.1312","article-title":"The current state and future perspectives of cannabinoids in cancer biology","volume":"7","author":"Zeyland","year":"2018","journal-title":"Cancer Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","article-title":"Medical use of cannabinoids","volume":"78","year":"2018","journal-title":"Drugs"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1111\/bph.14331","article-title":"Insights into the effects of the endocannabinoid system in cancer: A review","volume":"175","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","article-title":"The endocannabinoid system and cancer: Therapeutic implication","volume":"163","author":"Guindon","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Laezza, C., Pagano, C., Navarra, G., Pastorino, O., Proto, M.C., Fiore, D., Piscopo, C., Gazzerro, P., and Bifulco, M. (2020). The endocannabinoid system: A target for cancer treatment. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030747"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.breast.2018.06.009","article-title":"Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines","volume":"41","author":"Sultan","year":"2018","journal-title":"Breast"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","article-title":"Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis","volume":"129","author":"McAllister","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/1535-7163.MCT-07-0371","article-title":"Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells","volume":"6","author":"McAllister","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fonc.2019.00480","article-title":"Breast cancer subtypes present a differential production of reactive oxygen species (ROS) and susceptibility to antioxidant treatment","volume":"9","author":"Pelayo","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-407190-2.00003-4","article-title":"Role of oxidative stress and the microenvironment in breast cancer development and progression","volume":"119","author":"Rosenzweig","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"ref_119","unstructured":"Chen, K., Lu, P., Beeraka, N.M., Sukocheva, O.A., Madhunapantula, S.V., Liu, J., Sinelnikov, M.Y., Nikolenko, V.N., Bulygin, K.V., and Mikhaleva, L.M. (2020). Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers. Semin. Cancer Biol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Schoeman, R., Beukes, N., and Frost, C. (2020). Cannabinoid combination induces cytoplasmic vacuolation in MCF-7 breast cancer cells. Molecules, 25.","DOI":"10.3390\/molecules25204682"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1535-7163.MCT-09-0448","article-title":"Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer","volume":"8","author":"Qamri","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2005.10.024","article-title":"Anandamide inhibits adhesion and migration of breast cancer cells","volume":"312","author":"Grimaldi","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1677\/ERC-08-0030","article-title":"The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA\/RHO kinase signaling pathway","volume":"15","author":"Laezza","year":"2008","journal-title":"Endocr-Relat. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Nasser, M.W., Qamri, Z., Deol, Y.S., Smith, D., Shilo, K., Zou, X., and Ganju, R.K. (2011). Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023901"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-9-196","article-title":"Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition","volume":"9","author":"Caffarel","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","article-title":"The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation","volume":"95","author":"Melck","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/endo.141.1.7239","article-title":"Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation","volume":"141","author":"Melck","year":"2000","journal-title":"Endocrinology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-5793(99)01639-7","article-title":"Involvement of the cAMP\/protein kinase a pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells","volume":"463","author":"Melck","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/onc.2008.145","article-title":"JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells","volume":"27","author":"Caffarel","year":"2008","journal-title":"Oncogene"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1158\/0008-5472.CAN-05-4566","article-title":"Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation","volume":"66","author":"Caffarel","year":"2006","journal-title":"Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tox.2007.12.019","article-title":"Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling","volume":"245","author":"Takeda","year":"2008","journal-title":"Toxicology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tox.2004.08.005","article-title":"Marijuana extracts possess the effects like the endocrine disrupting chemicals","volume":"206","author":"Watanabe","year":"2005","journal-title":"Toxicology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2009.01.024","article-title":"Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase","volume":"259","author":"Takeda","year":"2009","journal-title":"Toxicology"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"De la Harpe, A., Beukes, N., and Frost, C.L. (2021). CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines. Biotechnol. Appl. Biochem.","DOI":"10.1002\/bab.2119"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"105876","DOI":"10.1016\/j.jsbmb.2021.105876","article-title":"Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors","volume":"210","author":"Amaral","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1080\/07391102.2020.1737233","article-title":"Insight of druggable cannabinoids against estrogen receptor \u03b2 in breast cancer","volume":"39","author":"Bhattacharjee","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_137","first-page":"85","article-title":"Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells","volume":"28","author":"Schlumpf","year":"2008","journal-title":"Anticancer. Res."},{"key":"ref_138","first-page":"158512","article-title":"Anandamide targets aromatase: A breakthrough on human decidualization","volume":"1864","author":"Almada","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.reprotox.2020.01.003","article-title":"Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling","volume":"93","author":"Almada","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","article-title":"Appraising the \u201centourage effect\u201d: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer","volume":"157","author":"Benito","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2013.10.057","article-title":"CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen","volume":"441","author":"Prather","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/tx4000446","article-title":"\u03949-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor \u03b2 (ER\u03b2)","volume":"26","author":"Takeda","year":"2013","journal-title":"Chem. Res. Toxicol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/1\/156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:54:37Z","timestamp":1760169277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/1\/156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["molecules27010156"],"URL":"https:\/\/doi.org\/10.3390\/molecules27010156","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}